2014-001532-11: ACTIVITY OF R-CHOP CHEMOIMMUNOTHERAPY BY NGR-TUMOR NECROSIS FACTOR IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA |
|
|
| Ongoing | 2 | 10 | Europe | ARENEGYR, Ngr-TNF, Solution for injection | Ospedale San Raffaele, Ospedale San Raffaele | Primary non-Hodgkin lymphoma in the central nervous system relapse / refractory Linfoma non Hodgkin primitivo del Sistema nervoso centrale in ricaduta/refrattario, cancer of the lymphocytes localized exclusively at the level of the central nervous system unresponsive or relapsed after at least one line of therapy tumore dei linfociti localizzato esclusivamente a livello del sistema nervoso centrale non responsivo o ricaduto dopo almeno una linea di terapia, Diseases [C] - Blood and lymphatic diseases [C15] | | | | |
